Publications - Brooks S. Edwards, M.D.

Back to research profile

  1. Swiecicki PL, Edwards BS, Kushwaha SS, Dispenzieri A, Park SJ, Gertz MA. Left ventricular device implantation for advanced cardiac amyloidosis. J Heart Lung Transplant. 2013 May; 32(5):563-8. Epub 2013 Mar 06.
    View PubMed
  2. Topilsky Y, Raichlin E, Hasin T, Boilson BA, Schirger JA, Pereira NL, Edwards BS, Clavell AL, Rodeheffer RJ, Frantz RP, Gandhi MJ, Maltais S, Park SJ, Daly RC, Lerman A, Kushwaha SS. Combined heart and liver transplant attenuates cardiac allograft vasculopathy compared with isolated heart transplantation. Transplantation. 2013 Mar 27; 95(6):859-65.
    View PubMed
  3. Topilsky Y, Gandhi MJ, Hasin T, Voit LL, Raichlin E, Boilson BA, Schirger JA, Edwards BS, Clavell AL, Rodeheffer RJ, Frantz RP, Kushwaha SS, Lerman A, Pereira NL. Donor-specific antibodies to class II antigens are associated with accelerated cardiac allograft vasculopathy: a three-dimensional volumetric intravascular ultrasound study. Transplantation. 2013 Jan 27; 95(2):389-96.
    View PubMed
  4. Daly RC, Topilsky Y, Joyce L, Hasin T, Gandhi M, Rosen C, Heimbach J, Edwards BS, Pereira N, Stulak JM, Arendt CJ, Park SJ, Kushwaha SS. Combined heart and liver transplantation: protection of the cardiac graft from antibody rejection by initial liver implantation. Transplantation. 2013 Jan 27; 95(2):e2-4.
    View PubMed
  5. Hasin T, Marmor Y, Kremers W, Topilsky Y, Severson CJ, Schirger JA, Boilson BA, Clavell AL, Rodeheffer RJ, Frantz RP, Edwards BS, Pereira NL, Stulak JM, Joyce L, Daly R, Park SJ, Kushwaha SS. Readmissions after implantation of axial flow left ventricular assist device. J Am Coll Cardiol. 2013 Jan 15; 61(2):153-63. Epub 2012 Dec 05.
    View PubMed
  6. Hasin T, Topilsky Y, Kremers WK, Boilson BA, Schirger JA, Edwards BS, Clavell AL, Rodeheffer RJ, Frantz RP, Joyce L, Daly R, Stulak JM, Kushwaha SS, Park SJ, Pereira NL. Usefulness of the six-minute walk test after continuous axial flow left ventricular device implantation to predict survival. Am J Cardiol. 2012 Nov 1; 110(9):1322-8. Epub 2012 Jul 21.
    View PubMed
  7. Jowsey SG, Cutshall SM, Colligan RC, Stevens SR, Kremers WK, Vasquez AR, Edwards BS, Daly RC, McGregor CG. Seligman's theory of attributional style: optimism, pessimism, and quality of life after heart transplant. Prog Transplant. 2012 Mar; 22(1):49-55.
    View PubMed
  8. Topilsky Y, Hasin T, Raichlin E, Boilson BA, Schirger JA, Pereira NL, Edwards BS, Clavell AL, Rodeheffer RJ, Frantz RP, Maltais S, Park SJ, Daly RC, Lerman A, Kushwaha SS. Sirolimus as primary immunosuppression attenuates allograft vasculopathy with improved late survival and decreased cardiac events after cardiac transplantation. Circulation. 2012 Feb 7; 125(5):708-20. Epub 2011 Dec 29.
    View PubMed
  9. Hasin T, Topilsky Y, Schirger JA, Li Z, Zhao Y, Boilson BA, Clavell AL, Rodeheffer RJ, Frantz RP, Edwards BS, Pereira NL, Joyce L, Daly R, Park SJ, Kushwaha SS. Changes in renal function after implantation of continuous-flow left ventricular assist devices. J Am Coll Cardiol. 2012 Jan 3; 59(1):26-36.
    View PubMed
  10. Gandhi MJ, DeGoey SR, Bundy K, Kremers WK, Knauer R, Pereira N, Edwards B, Kushwaha S, Daly RC. Effect of pretransplant human leukocyte antigen antibodies detected by solid-phase assay on heart transplant outcomes. Transplant Proc. 2011 Dec; 43(10):3840-6.
    View PubMed
  11. Raichlin E, Al-Omari MA, Hayes CL, Edwards BS, Frantz RP, Boilson BA, Clavell AL, Rodeheffer RJ, Schirger JA, Kushwaha SS, Allison TG, Pereira NL. Cardiac allograft hypertrophy is associated with impaired exercise tolerance after heart transplantation. J Heart Lung Transplant. 2011 Oct; 30(10):1153-60. Epub 2011 May 31.
    View PubMed
  12. Raichlin E, Kushwaha SS, Daly RC, Kremers WK, Frantz RP, Clavell AL, Rodeheffer RJ, Larson TS, Stegall MD, McGregor C, Pereira NL, Edwards BS. Combined heart and kidney transplantation provides an excellent survival and decreases risk of cardiac cellular rejection and coronary allograft vasculopathy. Transplant Proc. 2011 Jun; 43(5):1871-6.
    View PubMed
  13. Amer H, Carlsen BT, Dusso JL, Edwards BS, Moran SL. Hand transplantation. Minn Med. 2011 May; 94(5):40-3.
    View PubMed
  14. Terzic A, Edwards BS, McKee KC, Nelson TJ. Regenerative medicine: a reality of stem cell technology. Minn Med. 2011 May; 94(5):44-7.
    View PubMed
  15. Sareyyupoglu B, Boilson BA, Durham LA, McGregor CG, Daly RC, Redfield MM, Edwards BS, Frantz RP, Pereira NL, Park SJ. B-type natriuretic peptide levels and continuous-flow left ventricular assist devices. ASAIO J. 2010 Nov-Dec; 56(6):527-31.
    View PubMed
  16. Rogers JG, Aaronson KD, Boyle AJ, Russell SD, Milano CA, Pagani FD, Edwards BS, Park S, John R, Conte JV, Farrar DJ, Slaughter MS, HeartMate II Investigators. Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients. J Am Coll Cardiol. 2010 Apr 27; 55(17):1826-34.
    View PubMed
  17. Raichlin E, Daly RC, Rosen CB, McGregor CG, Charlton MR, Frantz RP, Clavell AL, Rodeheffer RJ, Pereira NL, Kremers WK, Kushwaha SS, Edwards BS. Combined heart and liver transplantation: a single-center experience. Transplantation. 2009 Jul 27; 88(2):219-25.
    View PubMed
  18. Raichlin E, Prasad A, Kremers WK, Edwards BS, Rihal CS, Lerman A, Kushwaha SS. Sirolimus as primary immunosuppression is associated with improved coronary vasomotor function compared with calcineurin inhibitors in stable cardiac transplant recipients. Eur Heart J. 2009 Jun; 30(11):1356-63. Epub 2009 Apr 21.
    View PubMed
  19. Raichlin E, Kushwaha SS, Lennon RJ, Frantz RP, Edwards BS, Prasad A, Rihal CS, Lerman A. Features of cardiac allograft coronary endothelial dysfunction. Am J Cardiol. 2009 Apr 15; 103(8):1154-8. Epub 2009 Feb 28.
    View PubMed
  20. Raichlin E, Edwards BS, Kremers WK, Clavell AL, Rodeheffer RJ, Frantz RP, Pereira NL, Daly RC, McGregor CG, Lerman A, Kushwaha SS. Acute cellular rejection and the subsequent development of allograft vasculopathy after cardiac transplantation. J Heart Lung Transplant. 2009 Apr; 28(4):320-7.
    View PubMed
  21. Mateen FJ, van de Beek D, Kremers WK, Daly RC, Edwards BS, McGregor CG, Wijdicks EF. Neuromuscular diseases after cardiac transplantation. J Heart Lung Transplant. 2009 Mar; 28(3):226-30.
    View PubMed
  22. Raichlin E, Villarraga HR, Chandrasekaran K, Clavell AL, Frantz RP, Kushwaha SS, Rodeheffer RJ, McGregor CG, Daly RC, Park SJ, Kremers WK, Edwards BS, Pereira NL. Cardiac allograft remodeling after heart transplantation is associated with increased graft vasculopathy and mortality. Am J Transplant. 2009 Jan; 9(1):132-9. Epub 2008 Nov 27.
    View PubMed
  23. Raichlin E, Chandrasekaran K, Kremers WK, Frantz RP, Clavell AL, Pereira NL, Rodeheffer RJ, Daly RC, McGregor CG, Edwards BS, Kushwaha SS. Sirolimus as primary immunosuppressant reduces left ventricular mass and improves diastolic function of the cardiac allograft. Transplantation. 2008 Nov 27; 86(10):1395-400.
    View PubMed
  24. Lacy MQ, Dispenzieri A, Hayman SR, Kumar S, Kyle RA, Rajkumar SV, Edwards BS, Rodeheffer RJ, Frantz RP, Kushwaha SS, Clavell AL, Dearani JA, Sundt TM, Daly RC, McGregor CG, Gastineau DA, Litzow MR, Gertz MA. Autologous stem cell transplant after heart transplant for light chain (Al) amyloid cardiomyopathy. J Heart Lung Transplant. 2008 Aug; 27(8):823-9. Epub 2008 Jul 03.
    View PubMed
  25. van de Beek D, Kremers WK, Del Pozo JL, Daly RC, Edwards BS, McGregor CG, Patel R. Effect of infectious diseases on outcome after heart transplant. Mayo Clin Proc. 2008 Mar; 83(3):304-8.
    View PubMed
  26. van de Beek D, Kremers W, Daly RC, Edwards BS, Clavell AL, McGregor CG, Wijdicks EF. Effect of neurologic complications on outcome after heart transplant. Arch Neurol. 2008 Feb; 65(2):226-31.
    View PubMed
  27. Raichlin E, Bae JH, Khalpey Z, Edwards BS, Kremers WK, Clavell AL, Rodeheffer RJ, Frantz RP, Rihal C, Lerman A, Kushwaha SS. Conversion to sirolimus as primary immunosuppression attenuates the progression of allograft vasculopathy after cardiac transplantation. Circulation. 2007 Dec 4; 116(23):2726-33. Epub 2007 Nov 19.
    View PubMed
  28. Otley CC, Griffin MD, Charlton MR, Edwards BS, Neuburg M, Stasko T, Reduction of Immunosuppression Task Force of the International Transplant, Skin Cancer Collaborative. Reduction of immunosuppression for transplant-associated skin cancer: thresholds and risks. Br J Dermatol. 2007 Dec; 157(6):1183-8. Epub 2007 Oct 04.
    View PubMed
  29. Raichlin E, Khalpey Z, Kremers W, Frantz RP, Rodeheffer RJ, Clavell AL, Edwards BS, Kushwaha SS. Replacement of calcineurin-inhibitors with sirolimus as primary immunosuppression in stable cardiac transplant recipients. Transplantation. 2007 Aug 27; 84(4):467-74.
    View PubMed
  30. Raichlin ER, McConnell JP, Lerman A, Kremers WK, Edwards BS, Kushwaha SS, Clavell AL, Rodeheffer RJ, Frantz RP. Systemic inflammation and metabolic syndrome in cardiac allograft vasculopathy. J Heart Lung Transplant. 2007 Aug; 26(8):826-33.
    View PubMed
  31. Bae JH, Rihal CS, Edwards BS, Kushwaha SS, Mathew V, Prasad A, Holmes DR Jr, Lerman A. Association of angiotensin-converting enzyme inhibitors and serum lipids with plaque regression in cardiac allograft vasculopathy. Transplantation. 2006 Oct 27; 82(8):1108-11.
    View PubMed
  32. Ahmari SA, Bunch TJ, Chandra A, Chandra V, Ujino K, Daly RC, Kushwaha SS, Edwards BS, Maalouf YF, Seward JB, McGregor CG, Chandrasekaran K. Prevalence, pathophysiology, and clinical significance of post-heart transplant atrial fibrillation and atrial flutter. J Heart Lung Transplant. 2006 Jan; 25(1):53-60. Epub 2005 Nov 02.
    View PubMed
  33. Miller WL, Edwards BS, Kremers WK, Kushwaha SS, McGregor CGA, Daly RC, Jaffe AS. Elevated donor troponin levels are associated with a lower frequency of allograft vasculopathy. J Heart Lung Transplant. 2005 Dec; 24(12):2075-8.
  34. Kushwaha SS, Khalpey Z, Frantz RP, Rodeheffer RJ, Clavell AL, Daly RC, McGregor CG, Edwards BS. Sirolimus in cardiac transplantation: Use as a primary immunosuppressant in calcineurin inhibitor-induced nephrotoxicity. J Heart Lung Transplant. 2005 Dec; 24(12):2129-36.
  35. Ocel JJ, Edwards WD, Tazelaar HD, Petrovic LM, Edwards BS, Kamath PS. Heart and liver disease in 32 patients undergoing biopsy of both organs, with implications for heart or liver transplantation. Mayo Clin Proc. 2004 Apr; 79(4):492-501.
    View PubMed
  36. Pittock SJ, Rabinstein AA, Edwards BS, Wijdicks EFM. OKT3 neurotoxicity presenting as akinetic mutism. Transplantation. 2003 Apr 15; 75(7):1058-60.
    View PubMed
  37. Leung TC, Ballman KV, Allison TG, Wagner JA, Olson LJ, Frantz RP, Edwards BS, Dearani JA, Daly RC, McGregor CG, Rodeheffer RJ. Clinical predictors of exercise capacity 1 year after cardiac transplantation. J Heart Lung Transplant. 2003 Jan; 22(1):16-27.
    View PubMed
  38. Squires RW, Leung TC, Cyr NS, Allison TG, Johnson BD, Ballman KV, Wagner JA, Olson LJ, Frantz RP, Edwards BS, Kushwaha SS, Dearani JA, Daly RC, McGregor CG, Rodeheffer RJ. Partial normalization of the heart rate response to exercise after cardiac transplantation: frequency and relationship to exercise capacity. Mayo Clin Proc. 2002 Dec; 77(12):1295-300.
    View PubMed
  39. Edwards BS. Medical Credibility on the Web: What to look for and What to Look Out For. Absolute Advantage The Workplace Wellness Magazine. 2002 Nov/December; 2(1):12-13.
  40. Razonable RR, Patel R, Wilhelm MP, Gertz MA, Litzow MR, Inwards DJ, Dearani JA, Edwards BS, McGregor CG. Fatal disseminated aspergillosis following sequential heart and stem cell transplantation for systemic amyloidosis. Am J Transplant. 2001 May; 1(1):93-5.
    View PubMed
  41. Casanova JB, Daly RC, Edwards BS, Tazelaar HD, Thompson GB. Intracardiac ectopic thyroid. Ann Thorac Surg. 2000 Nov; 70(5):1694-6.
    View PubMed
  42. Handa N, McGregor CG, Daly RC, Dearani JA, Edwards BS, Frantz RP, Olson LJ, Rodeheffer RJ. Heart transplantation for radiation-associated end-stage heart failure. Transpl Int. 2000; 13(2):162-5.
    View PubMed
  43. Kottke TE, Edwards BS, Hagen PT. Counseling: implementing our knowledge in a hurried and complex world. Am J Prev Med. 1999 Nov; 17(4):295-8.
    View PubMed
  44. Kamath PS, Tyce GM, Miller VM, Edwards BS, Rorie DK. Endothelin-1 modulates intrahepatic resistance in a rat model of noncirrhotic portal hypertension. Hepatology. 1999 Aug; 30(2):401-7.
    View PubMed
  45. Nemec J, Edwards BS, Osborn MJ, Edwards WD. Arrhythmogenic right ventricular dysplasia masquerading as dilated cardiomyopathy. Am J Cardiol. 1999 Jul 15; 84(2):237-9, A9.
    View PubMed
  46. Edwards BS. A stop at the oasis; lessons from Mayo Clinics popular web site. Minn Med. 1999; 82:28-31.
    View PubMed
  47. Fonseca R, Witzig TE, Olson LJ, Edwards BS, Khoor A, Walker RC. Disseminated Kaposi's sarcoma after heart transplantation: association with Kaposi's sarcoma-associated herpesvirus. J Heart Lung Transplant. 1998 Jul; 17(7):732-6.
    View PubMed
  48. Connolly HM, Crary JL, McGoon MD, Hensrud DD, Edwards BS, Edwards WD, Schaff HV. Valvular heart disease associated with fenfluramine-phentermine. N Engl J Med. 1997 Aug 28; 337(9):581-8.
    View PubMed
  49. Frantz RP, Edwards BS, Olson LJ, Schwab MK, Adams TF, Textor SC, Daly RC, McGregor CG, Rodeheffer RJ. Effects of pentoxifylline on renal function and blood pressure in cardiac transplant recipients: a randomized trial. Transplantation. 1997 Jun 15; 63(11):1607-10.
    View PubMed
  50. Chau EMC, Bailey KR, Mahoney DW, Frantz RP, McGregor CGA, Daly RC, Edwards BS, Olson LJ, Rodeheffer RJ. Predictors of reversibility of pulmonary hypertension in cardiac transplant recipients in the first postoperative year. Circulation. 1996 Nov 1; 94(9 Suppl S):267-272.
    View PubMed
  51. Allison T, Bardsley WT, Behrenbeck T, Christian TF, Clements IP, Edwards BS, Gibbons RJ, Miller TD, Oh JK, Pellikka PA, Roger VL, Squires RW, Weissler AM. Cardiovascular stress testing - a description of the various types of stress tests and indications for their use. Mayo Clin Proc. 1996 Jan; 71(1):43-52.
    View PubMed
  52. Chau EM, McGregor CG, Rodeheffer RJ, Frantz RP, Olson LJ, Daly RC, Edwards BS. Increased incidence of chronotropic incompetence in older donor hearts. J Heart Lung Transplant. 1995 Jul-Aug; 14(4):743-8.
    View PubMed
  53. Berger PB, Jones JD, Olson LJ, Edwards BS, Frantz RP, Rodeheffer RJ, Kottke BA, Daly RC, McGregor CG. Increase in total plasma homocysteine concentration after cardiac transplantation. Mayo Clin Proc. 1995 Feb; 70(2):125-31.
    View PubMed
  54. Frantz RP, Lerman A, Edwards BS, Olson LJ, Higano ST, Schwartz RS, Daly RC, McGregor CG, Rodeheffer RJ. Methylergonovine-induced diffuse coronary spasm in a patient with exercise-induced coronary spasm after heart transplantation. J Heart Lung Transplant. 1994 Sep-Oct; 13(5):834-9.
    View PubMed
  55. Lloyd MA, Grogan M, Sandberg SM, Smith HC, Gersh BJ, Edwards WD, Edwards BS. Presence of atrial natriuretic factor in ventricular tissue in tachycardia-induced cardiomyopathy. (Note). Am J Cardiol. 1994 May 15; 73:984-6.
    View PubMed
  56. Harrity PJ, Tazelaar HD, Edwards BS, Rodeheffer RJ. Diagnosis of coronary artery atheroembolism by right ventricular endomyocardial biopsy. Chest. 1994 Feb; 105(2):632-4.
    View PubMed
  57. Vigneswaran WT, Edwards BS, McGregor CG. Extended donor use for heart transplantation. Ann Thorac Surg. 1993 Sep; 56(3):552-3.
    View PubMed
  58. Edwards BS, Lloyd MA, Anderson LM. The synergistic effects of cyclosporine and endothelin--demonstration of an important cardiodepressor action. Transplantation. 1993 Jan; 55(1):8-11.
    View PubMed
  59. Edwards BS, Edwards JE. Congestive heart failure in rheumatic carditis: valvular or myocardial origin? J Am Coll Cardiol. 1993; 22:830-1.
    View PubMed
  60. Evans MA, Schomberg PJ, Rodeheffer RJ, Katzmann JA, Schnell WA Jr, Tazelaar HD, McGregor CGA, Edwards BS. Total lymphoid irradiation: a novel and successful therapy for resistant cardiac allograft rejection. (Symposium on cardiac transplantation-- part IV). Mayo Clin Proc. 1992 Aug; 67(8):785-90.
    View PubMed
  61. Ciresi DL, Lloyd MA, Sandberg SM, Heublein DM, Edwards BS. The sodium retaining effects of cyclosporine. Kidney Int. 1992 Jun; 41(6):1599-605.
    View PubMed
  62. Lloyd MA, Sandberg SM, Edwards BS. Role of renal Na+,K(+)-ATPase in the regulation of sodium excretion under normal conditions and in acute congestive heart failure. Circulation. 1992 May; 85(5):1912-7.
    View PubMed
  63. Edwards BS, Rodeheffer RJ. Prognostic features in patients with congestive heart failure and selection criteria for cardiac transplantation. Mayo Clin Proc. 1992 May; 67(5):485-92.
    View PubMed
  64. Perrella MA, Schwab TR, O'Murchu B, Redfield MM, Wei CM, Edwards BS, Burnett JC Jr. Cardiac atrial natriuretic factor during evolution of congestive heart failure. Am J Physiol. 1992 Apr; 262(4 Pt 2):H1248-55.
    View PubMed
  65. Lerman A, Edwards BS, Hallett JW, Heublein DM, Sandberg SM, Burnett JC Jr. Immunoreacttivita dell'endotelina circolante e tissutale nell'aterosclerosi avanzata. Focus on endothelium and vascular diseases 2 ( 1992; 2):44-7.
  66. Edwards BS, Rodeheffer RJ. Prognostic feastures in patients with congestive heart failure and selection criteria for cardiac transplantation. Mayo Clin Proc. 1992; 67:719-24.
  67. Lerman A, Edwards BS, Hallett JW, Heublein DM, Sandberg SM, Burnett JC Jr. Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. N Engl J Med. 1991 Oct 3; 325(14):997-1001.
    View PubMed
  68. Edwards BS, Hunt SA, Fowler MB, Valantine HA, Anderson LM, Lerman A. Effect of cyclosporine on plasma endothelin levels in humans after cardiac transplantation. Am J Cardiol. 1991 Apr 1; 67:782-784.
    View PubMed
  69. Lerman A, Edwards BS, Hallett JW, Heublein DM, Sandberg SM, Burnett JC Jr. Endotheline circulate et tissulaire dans l'atherosclerose grave. Le Journal International De Medecine. 1991; 214:27-33.
  70. Edwards BS, Rodeheffer RJ, Reeder GS, Burnett JC Jr. Expression of atrial natriuretic factor in the human ventricle is independent of chamber dilation. J Am Coll Cardiol. 1990 Dec; 16(7):1589-93.
    View PubMed
  71. Edwards BS. Recent advances in cardiac transplantation. Curr Opin Cardiol. 1990 Jun; 5(3):295-9.
    View PubMed
  72. Miller WL, Edwards BS, Zimmerman RS, Burnett JC Jr. Renal-endocrine adaptations to endogenous atrial natriuretic factor during tachycardia-induced reductions in renal perfusion pressure. Circ Res. 1990 Jan; 66(1):76-83.
    View PubMed
  73. Edwards BS, Hunt SA, Fowler MB, Valantine HA , Stinson EB , Schroeder JS . Cardiac transplantation in patients with preexisting neoplastic diseases. Am J Cardiol. 1990; 64:501-4.
  74. Lee ME, Miller WL, Edwards BS, Burnett JC Jr. Role of endogenous atrial natriuretic factor in acute congestive heart failure. J Clin Invest. 1989 Dec; 84(6):1962-6.
    View PubMed
  75. Redfield MM, Edwards BS, Heublein DM, Burnett JC Jr. Restoration of renal response to atrial natriuretic factor in experimental low-output heart failure. Am J Physiol. 1989 Oct; 257(4 Pt 2):R917-23.
    View PubMed
  76. Redfield MM, Edwards BS, McGoon MD, Heublein DM, Aarhus LL, Burnett JC Jr. Failure of atrial natriuretic factor to increase with volume expansion in acute and chronic congestive heart failure in the dog. Circulation. 1989 Sep; 80(3):651-7.
    View PubMed


Appointments | Contact Us | Give to Mayo Clinic | Search

LEGAL RESTRICTIONS AND TERMS OF USE APPLICABLE TO THIS SITE

Use of this site signifies your agreement to the terms of use.
© 2013 Mayo Foundation for Medical Education and Research. All rights reserved.